Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.

scientific article published on 10 January 2006

Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YGYNO.2005.10.039
P698PubMed publication ID16376417

P2093author name stringDavid Cella
Howard T Thaler
David H Moore
Richard P McQuellon
P2860cites workRandomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group studyQ71975328
Remission of metastatic cervical adenocarcinoma with weekly paclitaxelQ73819054
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group studyQ80396730
General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G)Q81685445
Cancer statistics, 2005Q29617572
Using data from studies of health-related quality of life to describe clinical issues examples from a longitudinal study of patients with advanced stages of cervical cancerQ30597640
The Functional Assessment of Cancer Therapy scale: development and validation of the general measureQ34361336
Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trialQ43998644
Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy.Q52895249
Which dimensions of health-related quality of life are altered in patients attending the different gynecologic oncology health care settings?Q53405292
Prospective assessment of quality of life of female cancer patients.Q53443717
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.Q53450591
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.Q53531493
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectcisplatinQ412415
paclitaxelQ423762
gynecologic oncologyQ5625186
P304page(s)296-304
P577publication date2006-01-10
P1433published inGynecologic OncologyQ5625182
P1476titleQuality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
P478volume101